ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Tourmaline Bio Inc

Tourmaline Bio Inc (TRML)

25.75
0.23
(0.90%)
Closed October 15 4:00PM
25.75
0.00
( 0.00% )
Pre Market: 7:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
25.75
Bid
24.76
Ask
27.50
Volume
-
0.00 Day's Range 0.00
9.18 52 Week Range 48.31
Market Cap
Previous Close
25.75
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
199,346
Shares Outstanding
25,641,363
Dividend Yield
-
PE Ratio
-15.67
Earnings Per Share (EPS)
-1.64
Revenue
-
Net Profit
-42.12M

About Tourmaline Bio Inc

Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and ... Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Tourmaline Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TRML. The last closing price for Tourmaline Bio was $25.75. Over the last year, Tourmaline Bio shares have traded in a share price range of $ 9.18 to $ 48.31.

Tourmaline Bio currently has 25,641,363 shares outstanding. The market capitalization of Tourmaline Bio is $660.27 million. Tourmaline Bio has a price to earnings ratio (PE ratio) of -15.67.

TRML Latest News

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress

NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board

– Tourmaline assembles leading experts to support the development of pacibekitug for cardiovascular diseases – – Cardiovascular Scientific Advisory Board expected to provide strategic guidance as...

Tourmaline Bio to Present at Upcoming Investor Conferences

NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.8-9.8073555166428.5528.864723.924462225.6688043CS
46.3832.937532266419.3728.864719.3733350724.9241739CS
1210.2966.558861578315.4628.864713.0319934621.25512319CS
266.4433.350595546319.3128.864712.1226484117.11533602CS
5215.43149.51550387610.3248.319.1825984922.80700048CS
15615.43149.51550387610.3248.319.1825984922.80700048CS
26015.43149.51550387610.3248.319.1825984922.80700048CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STECSantech Holdings Limited
$ 2.73
(609.83%)
17.05M
VSVersus Systems Inc
$ 4.87
(323.48%)
21.4M
BDRXBiodexa Pharmaceuticals PLC
$ 11.00
(119.56%)
2.29M
CTCXCarmell Corporation
$ 0.483
(39.72%)
5.86M
DUOFangDD Network Group Ltd
$ 1.22
(32.61%)
7.99M
EPRXEupraxia Pharmaceuticals Inc
$ 0.9328
(-61.61%)
65
PTIXProtagenic Therapeutics Inc
$ 0.3968
(-27.99%)
12
JDZGJIADE Ltd
$ 0.8819
(-20.55%)
326.12k
DBGIDigital Brands Group Inc
$ 0.1838
(-20.09%)
898.98k
DRUGBright Minds Biosciences Inc
$ 30.80
(-19.98%)
793.16k
VSVersus Systems Inc
$ 4.88
(324.35%)
21.4M
STECSantech Holdings Limited
$ 2.71
(604.63%)
17.05M
DUOFangDD Network Group Ltd
$ 1.22
(32.61%)
7.99M
XHGXChange TED Inc
$ 0.2209
(14.69%)
7.41M
CTCXCarmell Corporation
$ 0.483
(39.72%)
5.86M

Your Recent History

Delayed Upgrade Clock